Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin and Lansoprazole in Recent-Onset Type 1 Diabetes (REPAIR-T1D)
NCT01155284Phase 2Completed
- Sponsor
- Sanford Health
- Start
- Aug 2010
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sitagliptin and lansoprazole in type 1 diabetes mellitus (T1D), sponsored by Sanford Health. Primary endpoint: 2 Hour C-peptide Area Under the Curve at 12 months. Started Aug 2010; status: completed.
02
Drugs
sitagliptinlansoprazole
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01155284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01155284.